Evidence map›Paper›PMID 31947626›Full record

ArticleCancers2020

A Novel Cytological Model of B-Cell/Macrophage Biphenotypic Cell Hodgkin Lymphoma in

Yasuhiro Sakai, Andri Rezano, Seiji Okada, Takahiro Ohtsuki, Yoshiaki Kawashima, Tetsuya Tsukamoto, Motoshi Suzuki, Michinori Kohara, Motohiro Takeya, Nobuo Sakaguchi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Yasuhiro SakaiDepartment of Diagnostic Pathology, Fujita Health University School of Medicine, Aichi 470-1192, Japan.
Andri RezanoDepartment of Biomedical Sciences, Division of Cell Biology, Faculty of Medicine, Universitas Padjadjaran, West Java 45363, Indonesia.
Seiji OkadaDivision of Hematopoiesis, Joint Research Center for Retroviral Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Takahiro OhtsukiDepartment of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Yoshiaki KawashimaDepartment of Diagnostic Pathology, Fujita Health University School of Medicine, Aichi 470-1192, Japan.
Tetsuya TsukamotoDepartment of Diagnostic Pathology, Fujita Health University School of Medicine, Aichi 470-1192, Japan.
Motoshi SuzukiDepartment of Molecular Oncology, Fujita Health University School of Medicine, Aichi 470-1192, Japan.
Michinori KoharaDepartment of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Motohiro TakeyaDepartment of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Nobuo SakaguchiDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Kazuhiko KuwaharaDepartment of Diagnostic Pathology, Fujita Health University School of Medicine, Aichi 470-1192, Japan.
Fujita Health University · JPKumamoto University · JPTokyo Metropolitan Institute of Medical Science · JPPadjadjaran University · ID

Funding

Japan Society for the Promotion of Science 15K10083Japan Society for the Promotion of Science 16K15603Japan Society for the Promotion of Science 16K19078
6 · The paper itself

Abstract

Hodgkin lymphoma (HL) is one of the most difficult neoplasms in terms of cytopathological research owing to the lack of established cytological murine models. Although HL is believed to be of lymphoid germinal center B-cell origin, HL cells exhibit unique biphenotypic characteristics of B cells and macrophages. B-cell/macrophage biphenotypic cells have also been identified in the spleen of Lyn-deficient mice. Moreover, Lyn-targeting germinal center-associated nuclear protein (GANP)-transgenic mice (

Indexed as

B-cell/macrophage biphenotypic cellgerminal centergerminal center-associated nuclear proteinHodgkin lymphoma

Identifiers

PMID31947626
PMCPMC7017268
OpenAlexW2999214870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.